| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 01/05/2011 | EP2270049A2 Recombinant anti-interleukin-9-antibody |
| 01/05/2011 | EP2270047A2 Anti-C5 antibodies and their therapeutic uses |
| 01/05/2011 | EP2270046A2 Methods and compositions for the treatment of hemolysis-associated diseases |
| 01/05/2011 | EP2270042A2 KDR peptides and vaccines comprising the same |
| 01/05/2011 | EP2270041A2 KDR peptides and vaccines comprising the same |
| 01/05/2011 | EP2270008A1 1,3-dihydro-imidazo[4,5-c]quinolin-2-ones as lipid kinase and/or pi3 kinases inhibitors |
| 01/05/2011 | EP2270006A1 Pyridazine derivatives useful as vanilloid receptor ligands |
| 01/05/2011 | EP2270005A1 Prodrug of an ice inhibitor |
| 01/05/2011 | EP2270002A1 Quinazoline derivatives as histamine H4-receptor inhibitors for use in the treatment of inflammatory disorders |
| 01/05/2011 | EP2269988A2 Anthranilic acid amides and pharmaceutical use thereof |
| 01/05/2011 | EP2269656A2 Selected antibodies binding to anionic phospholipids and aminophospholipids and their use in treatment |
| 01/05/2011 | EP2269654A2 Enhancing drug delivery across and into epithelial tissues using oligo arginine moieties |
| 01/05/2011 | EP2269651A2 Stabilisation of macrolides |
| 01/05/2011 | EP2269650A2 Carrier for enteral administration |
| 01/05/2011 | EP2269622A1 CpG oligonucleotides used for enhancing steroid activity in a steroid dependent patient. |
| 01/05/2011 | EP2269598A2 Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2 |
| 01/05/2011 | EP2268638A1 Tetrahydronaphthyridines and aza derivatives thereof as histamine h3 receptor antagonists |
| 01/05/2011 | EP2268635A1 Heterocyclic compounds |
| 01/05/2011 | EP2268632A1 Tertiary amine derivatives as phosphodiesterase-4 inhibitors |
| 01/05/2011 | EP2268616A1 Substituted pyrrolidine and piperidine compounds, derivatives thereof, and methods for treating pain |
| 01/05/2011 | EP2268612A1 Arylsulfonamide-based matrix metalloprotease inhibitors |
| 01/05/2011 | EP1908467B1 Agent for treating herpesvirus-derived pain |
| 01/05/2011 | EP1905442B1 Utilization of anti-neuropathic pain effect of d-allose and d-psicose |
| 01/05/2011 | EP1720572B1 Monovalent ligand of the fcalphari receptor as an anti-inflammatory agent |
| 01/05/2011 | EP1661890B1 Ppar-activating compound and pharmaceutical composition containing same |
| 01/05/2011 | EP1542692B1 Aminopyrimidine derivatives for use as vanilloid receptor ligands for the treatment of pain |
| 01/05/2011 | EP1493034B1 Method for diagnosing inflammatory diseases and infections by the determination of lasp-1 immunoreactivity |
| 01/05/2011 | EP1463806B1 Novel cyclooxygenase variants and methods of use |
| 01/05/2011 | EP1446381B1 Anthranilic acid amides and pharmaceutical use thereof |
| 01/05/2011 | EP1401467B1 Alpha-fetoprotein peptides and uses thereof |
| 01/05/2011 | EP1365778B1 Treating pulmonary disorders with gaseous agent causing repletion of gsno |
| 01/05/2011 | EP1128814B1 Aerosols comprising nanoparticle drugs |
| 01/05/2011 | EP0968718B1 Remedies for ulcerative colitis |
| 01/05/2011 | CN101939424A Anti-nr10 antibody and use thereof |
| 01/05/2011 | CN101939337A Anti-TRKA antibodies and derivatives thereof |
| 01/05/2011 | CN101939324A Pyrrolopyrazine kinase inhibitors |
| 01/05/2011 | CN101939313A 3,8-diaminotetrahydroquinoline derivative |
| 01/05/2011 | CN101939027A Lipopeptides for delivery of nucleic acids |
| 01/05/2011 | CN101939004A Delayed release pharmaceutical composition of duloxetine |
| 01/05/2011 | CN101935604A Elapidae liquor and preparation method thereof |
| 01/05/2011 | CN101935349A Humanized monoclonal antibody against human vascular endothelial growth factor and preparation and application thereof |
| 01/05/2011 | CN101935345A Peptides and APL-type derivatives of HSP60 and pharmaceutical compositions |
| 01/05/2011 | CN101935334A Berberine glycyrrhetinic acid enantiomeric salts and preparation method and application thereof |
| 01/05/2011 | CN101935332A Preparation method and application of 5,7,4'-trihydroxyl8-methoxyl-3-O-alpha-L-rhamnoside and active composition thereof |
| 01/05/2011 | CN101935318A 2,3-dihydro-4(1H)- quinazolone derivative and application thereof |
| 01/05/2011 | CN101935315A Heteroaryl-tetrahydropiperidyl compounds useful for treating or preventing pain |
| 01/05/2011 | CN101935293A Method for preparing arginine ketoprofenate |
| 01/05/2011 | CN101934053A Chinese herbal medicament for treating sciatica |
| 01/05/2011 | CN101934051A Six-depression soup |
| 01/05/2011 | CN101934043A Clove pain-relief spray and preparation process thereof |
| 01/05/2011 | CN101934034A Chinese herbal medicine for treating trigeminal neuralgia |
| 01/05/2011 | CN101934024A Lingxian snake-scorpion plaster and manufacturing method thereof |
| 01/05/2011 | CN101934012A Gel ointment for treating rheumatic arthritis and traumatic injury |
| 01/05/2011 | CN101934010A Plaster for treating rheumatic diseases |
| 01/05/2011 | CN101934001A Medicament for treating rheumatic headache |
| 01/05/2011 | CN101933996A Chinese medicinal composition having effects of clearing heat, relieving fire and eliminating toxins and preparation and detection methods thereof |
| 01/05/2011 | CN101933991A Analgesic and anti-inflammatory medicament and preparation method thereof |
| 01/05/2011 | CN101933985A Liniment for skin functional care for old and weak people |
| 01/05/2011 | CN101933966A Active site composition of isatis roots, as well as preparation method and application thereof |
| 01/05/2011 | CN101933963A Nasal in-situ gel for treating headache |
| 01/05/2011 | CN101933962A Ligusticum wallichii formulation granule and preparation method thereof |
| 01/05/2011 | CN101933960A Method for identifying medicinal cyathula root and easily-confused species thereof |
| 01/05/2011 | CN101933932A Application of 4-cyan-beta-D-glucoside in treating chronic neurogenic pain |
| 01/05/2011 | CN101933926A Indolylmaleimde derivatives as PKC inhibitors |
| 01/05/2011 | CN101933925A Huperzine A with abirritation and derivatives thereof |
| 01/05/2011 | CN101933743A Traditional Chinese medical health pillow |
| 01/05/2011 | CN101606922B Glucosamine potassium sulfate microcapsule and preparation method and application thereof |
| 01/05/2011 | CN101569272B Method for inducing active leaves of dragon tree to generate dragon blood with fungus |
| 01/05/2011 | CN101507819B Large-grainsize medicine intercalated hydrotalcite and preparation method thereof |
| 01/05/2011 | CN101411799B Oral medicinal liquor for treating rheumatism and rheumatoid disease |
| 01/05/2011 | CN101361921B Medicinal liquor for treating lumbago and scelagia |
| 01/05/2011 | CN101297965B Applications of thymic peptide beta4 in preparing medicament for preventing and treating bronchial asthma |
| 01/05/2011 | CN101269160B Chinese medicinal composition for treating trigeminal neuralgia |
| 01/05/2011 | CN101264146B Externally-applied Chinese herbal medicine for treating bones and muscles disease and preparation thereof |
| 01/05/2011 | CN101089000B Spiro piperazine quaternary ammonium salt compound and its preparation method and application |
| 01/04/2011 | US7863454 4-[4-Isopropoxy-5-(5-isopropyl-2-methyl-phenoxymethyl)-6-methyl-pyridin-2-yl]-5-isopropyl-1H-indazole; binding antagonist and arylpyridine for antiinflammatory agents, cardiovascular disorders and antagonist or agonist and for immunology |
| 01/04/2011 | US7863327 Chemopreventative treatment of diseases such as cancer, Alzheimer's disease, Parkinson's disease, inflammatory bowel disease, and multiple sclerosis |
| 01/04/2011 | US7863314 Pyrazole and/or imidazole based compounds; inflammatory diseases and disorders; synthesis |
| 01/04/2011 | US7863313 Methods for the treatment of inflammatory diseases |
| 01/04/2011 | US7863312 Pyrazolidinone derivatives, e.g., 4-[2-(2-(3-hydroxyoctyl)-5-oxopyrazolidin-1-yl)ethyl]benzoic acid; treating preterm labor, dysmenorrhea, asthma, hypertension, infertility, sexual disorders, undesired blood clotting, bone disorders, (pre)eclampsia, or eosinophil disorders |
| 01/04/2011 | US7863289 Compounds and methods for kinase modulation, and indications therefor |
| 01/04/2011 | US7863278 Isethionate salt of a selective CDK4 inhibitor |
| 01/04/2011 | US7863241 Lung surfactant polypeptide, and at least one inhibitor of a mediator of tissue destruction; for example protease inhibitors; treating inflammatory lung conditions such as asthma, chronic obstructive pulmonary disease |
| 01/04/2011 | CA2558191C Composition containing benzamidine derivative and method for stabilizing benzamidine derivative |
| 01/04/2011 | CA2521271C Quinoline-2-one-derivatives for the treatment of airways diseases |
| 01/04/2011 | CA2493995C Macrolide compounds endowed with antiinflammatory activity |
| 01/04/2011 | CA2491871C Novel complexes of fatty acid esters of polyhydroxyalkanes and pyridine carboxy derivatives |
| 01/04/2011 | CA2488363C O-substituted hydroxyaryl derivatives |
| 01/04/2011 | CA2479362C N-sulfonylurea apoptosis promoters |
| 01/04/2011 | CA2462953C Substituted 4-phenyl-4-[1h-imidazol-2-yl]-piperidine derivatives and their use as selective non-peptide delta opioid agonists |
| 01/04/2011 | CA2460920C Stent coated with a sustained-release drug delivery and method for use thereof |
| 01/04/2011 | CA2460822C Aralkyltetrahydropyridines, their preparation and pharmaceutical compositions containing same |
| 01/04/2011 | CA2458533C Imidazole derivates as anti-inflammatory agents |
| 01/04/2011 | CA2454703C Novel thiophene carboxamide derivatives |
| 01/04/2011 | CA2451241C Unsymmetrical cyclic diamine compound |
| 01/04/2011 | CA2451238C Cyclic diamine compound with 5 membered ring groups |
| 01/04/2011 | CA2429312C Novel pyridine-substituted pyrazolopyridine derivatives |
| 01/04/2011 | CA2427750C Substituted alkanoic acids |
| 01/04/2011 | CA2419423C Conjugates of peptides and peptide mimetics having integrin inhibitor properties |
| 01/04/2011 | CA2413426C Methods and compositions utilizing quinazolinones |